MENU
CURE
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

CURE stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index... Show more

Category: #Trading
CURE
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for CURE with price predictions
Aug 21, 2026

CURE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CURE turned positive on August 10, 2026. Looking at past instances where CURE's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on CURE as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for CURE moved above the 200-day moving average on July 22, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 244 cases where CURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CURE moved out of overbought territory on August 20, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CURE broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. It is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Healthcare Bull 3X ETF ETF is 103.61B. The market cap for tickers in the group ranges from 9.86B to 1.12T. LLY holds the highest valuation in this group at 1.12T. The lowest valued company is HSIC at 9.86B.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Healthcare Bull 3X ETF ETF was 129%. For the same ETF, the average monthly price growth was 150%, and the average quarterly price growth was 191%. MRNA experienced the highest price growth at 129%, while ALGN experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Healthcare Bull 3X ETF ETF was 71%. For the same stocks of the ETF, the average monthly volume growth was 40% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 41
P/E Growth Rating: 42
Price Growth Rating: 30
SMR Rating: 58
Profit Risk Rating: 74
Seasonality Score: -28 (-100 ... +100)
View a ticker or compare two or three
CURE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
CURE's MACD Histogram just turned positive